Lei Guo

Lei Guo, PhD is a Research Assistant Professor at the Center for Epigenetics & Disease Prevention, Texas A&M University. Based in Houston, Texas, Dr. Guo focuses on epigenetic research with implications for understanding disease mechanisms and developing novel therapeutic approaches. His work bridges basic science and translational applications in cancer biology and developmental disorders.

Dr. Guo received his Ph.D. in Cancer Cell Biology from Xiamen University in China. His educational background has provided a strong foundation for his current research in epigenetic regulation and its role in human diseases.

Dr. Guo's research centers on understanding how DNA and histone modifications maintain homeostasis in humans and mammals, and how disruptions contribute to developmental defects, metabolic disorders, and oncogenesis. His work specifically investigates dynamic changes in DNA methylation, the impact of additional regulators on malignant transformation, and the development of innovative single-cell epigenome analysis and editing tools. He also utilizes high-throughput drug screening to discover new treatments for devastating diseases.

Analysis of Dr. Guo's publication record reveals a strong focus on epigenetic regulation, particularly concerning TET2 and DNMT3A proteins, DNA methylation, and their roles in cancer development and treatment resistance. His recent work shows increasing emphasis on biomolecular condensates, spatial genome organization, and the intersection of epigenetics with aging and immune cell function. The research spans from basic mechanisms to translational applications, with a growing trend toward therapeutic development.

Dr. Guo has not been mentioned as having specific scientific awards in the provided materials, but his publication record in high-impact journals demonstrates significant contributions to the field of epigenetics and cancer biology.

While specific information about Dr. Guo's advising activities and grant funding is not detailed in the provided materials, his research program appears substantial given the volume and quality of publications. His work likely involves collaboration with multiple researchers and institutions, as evidenced by the co-authorship patterns in his publications. The research program seems well-supported to conduct sophisticated epigenomic analyses and drug screening approaches.

Dr. Guo is affiliated with the Center for Epigenetics & Disease Prevention at Texas A&M University, suggesting he is part of a larger research team focused on understanding the epigenetic basis of disease. His work likely involves collaborations across multiple laboratories given the technical complexity of single-cell epigenome analysis, CRISPR-based epigenome editing, and high-throughput drug screening mentioned in his research goals.